Ajinomoto Bio-Pharma Services — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Ajinomoto Bio-Pharma Services is a Brussels-based CDMO founded in 2015, focusing on the contract development and manufacturing of biologics, including antibodies. As a subsidiary of the Japanese conglomerate Ajinomoto Co., Inc., it leverages its parent company's expertise in fermentation and bioprocessing. Its business model is purely service-based, supporting biotech and pharma clients from development through commercial supply. The company aims to capitalize on the growing global demand for outsourced biopharmaceutical manufacturing.

BiologicsAntibodiesDrug Delivery

Technology Platform

Bioprocessing and manufacturing platform for biologics and antibodies, leveraging Ajinomoto's expertise in fermentation, cell culture, and drug delivery/conjugation technologies.

Funding History

1

UndisclosedUndisclosedUndisclosedJun 15, 2021

Opportunities

The growing trend of biopharma outsourcing and the increasing complexity of biologic drugs, particularly antibody-drug conjugates (ADCs), present a significant growth opportunity.

Backing by the deep-pocketed and technically proficient Ajinomoto Group provides a strong foundation for capacity expansion and technological advancement.

Risk Factors

Faces intense competition from larger, global CDMOs and risks associated with client concentration and the failure of clients' clinical programs.

Operational execution risks, including manufacturing quality issues, could severely impact reputation and financial performance.

Competitive Landscape

Operates in the highly competitive global biologics CDMO market, competing against large players like Lonza, Catalent, and Fujifilm Diosynth, as well as many mid-sized and regional specialists. Differentiation is key and may be sought through niche expertise in conjugation/drug delivery and the technical legacy of its parent company.

More companies in Biologics / Biosimilars →More companies in Belgium →